Common Contracts
5 similar Note Purchase Agreement contracts by Revance Therapeutics, Inc., Osmotica Pharmaceuticals PLC, Puma Biotechnology, Inc., RVL Pharmaceuticals PLC
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [ *** ] INDICATES THAT INFORMATION HAS BEEN OMITTED. Execution Version FIRST AMENDMENT...Note Purchase Agreement • November 8th, 2023 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
FIRST AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., a Delaware corporation (the “Issuer”), RVL HOLDINGS US LLC, a Delaware limited liability company (“Intermediate Holdings”), RVL PHARMACEUTICALS PLC, an Irish public limited company (“Super Holdings”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, as the Administrative Agent.
NOTE PURCHASE AGREEMENT Dated as of March 18, 2022 among REVANCE THERAPEUTICS, INC., as the Issuer, CERTAIN SUBSIDIARIES OF THE ISSUER, as the Guarantors, ATHYRIUM BUFFALO LP, as the Administrative Agent and THE PURCHASERS FROM TIME TO TIME PARTY HERETONote Purchase Agreement • May 10th, 2022 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of March 18, 2022 among REVANCE THERAPEUTICS, INC., a Delaware corporation (the “Issuer”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM BUFFALO LP, as the Administrative Agent.
NOTE PURCHASE AGREEMENT Dated as of July 23, 2021 among PUMA BIOTECHNOLOGY, INC. as the Issuer, CERTAIN SUBSIDIARIES OF THE ISSUER, as the Guarantors, ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP as the Administrative Agent and THE PURCHASERS FROM TIME TO...Note Purchase Agreement • November 4th, 2021 • Puma Biotechnology, Inc. • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of July 23, 2021 among PUMA BIOTECHNOLOGY, INC., a Delaware corporation (the “Issuer”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, as the Administrative Agent.
NOTE PURCHASE AGREEMENT Dated as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., as the Issuer, OSMOTICA HOLDINGS US LLC, as Intermediate Holdings, OSMOTICA PHARMACEUTICALS PLC, as Super Holdings, CERTAIN SUBSIDIARIES OF SUPER HOLDINGS, as the...Note Purchase Agreement • October 6th, 2021 • Osmotica Pharmaceuticals PLC • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., a Delaware corporation (the “Issuer”), OSMOTICA HOLDINGS US LLC, a Delaware limited liability company (“Intermediate Holdings”), OSMOTICA PHARMACEUTICALS PLC, an Irish public limited company (“Super Holdings”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, as the Administrative Agent.
